Editorial comment on: Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels.

Editorial comment on: Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels. Eur Urol. 2009 Mar; 55(3):616.

View in: PubMed